US nod in Hand, Pfizer is looking for partners to make Covid drug in India

The company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of making treatment courses available as quickly as possible, pending authorisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3FqglXf
via IFTTT